| Tabitha Kuhn, LCSW | |
|
4616 Burgundy Pl, Lakeland, FL 33813-2301 | |
| (386) 559-0227 | |
| Not Available |
| Full Name | Tabitha Kuhn |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4616 Burgundy Pl, Lakeland, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033486477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | SW12941 (Florida) | Primary |
| 103K00000X | Behavior Analyst | (* (Not Available)) | Secondary |
| Entity Name | Internal Medicine Specialists Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760600142 PECOS PAC ID: 4981785094 Enrollment ID: O20080115000437 |
News Archive
A new approach to anchor teeth back in the jaw using stem cells has been developed and successfully tested in the laboratory for the first time by researchers at the University of Illinois at Chicago.
Many patients go without their prescribed medicine due to the slow or ineffective service of mail order pharmacies, according to a survey of just over 400 patients conducted by the National Community Pharmacists Association (NCPA). The findings both raise troubling questions about the impact mail-order programs have on patients and contradict two purported benefits of mail order: increased convenience and lower costs.
University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 4 days ago
| Entity Name | Conviva Medical Center Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649324278 PECOS PAC ID: 4284717422 Enrollment ID: O20080212000415 |
News Archive
A new approach to anchor teeth back in the jaw using stem cells has been developed and successfully tested in the laboratory for the first time by researchers at the University of Illinois at Chicago.
Many patients go without their prescribed medicine due to the slow or ineffective service of mail order pharmacies, according to a survey of just over 400 patients conducted by the National Community Pharmacists Association (NCPA). The findings both raise troubling questions about the impact mail-order programs have on patients and contradict two purported benefits of mail order: increased convenience and lower costs.
University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tabitha Kuhn, LCSW 4616 Burgundy Pl, Lakeland, FL 33813-2301 Ph: (385) 559-0227 | Tabitha Kuhn, LCSW 4616 Burgundy Pl, Lakeland, FL 33813-2301 Ph: (386) 559-0227 |
News Archive
A new approach to anchor teeth back in the jaw using stem cells has been developed and successfully tested in the laboratory for the first time by researchers at the University of Illinois at Chicago.
Many patients go without their prescribed medicine due to the slow or ineffective service of mail order pharmacies, according to a survey of just over 400 patients conducted by the National Community Pharmacists Association (NCPA). The findings both raise troubling questions about the impact mail-order programs have on patients and contradict two purported benefits of mail order: increased convenience and lower costs.
University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.
The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients.
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today announced that patient screening in its DSC127 Phase 2 trial in diabetic foot ulcer healing will be completed tomorrow, and that enrollment in the trial will conclude on September 30. This randomized, double-blind, placebo controlled study of up to 75 patients will look at the percentage of diabetic ulcers completely healed over a 12-week period, among other outcomes.
› Verified 4 days ago
Mrs. Heather Lynn Prociuk, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1140 State Road 540a, Lakeland, FL 33813 Phone: 863-608-0583 | |
Erin Walley Rivera, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5245 N Socrum Loop Rd, Lakeland, FL 33809 Phone: 863-859-1446 | |
Laura Braswell, M.DIV LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2625 Hollingsworth Hill Ave, Lakeland, FL 33803 Phone: 863-660-5243 | |
Ms. Khalilah Garrett, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 4541 Breccia Ln, Lakeland, FL 33811 Phone: 804-564-1308 | |
Michelle Means, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1825 Gilmore Ave, Lakeland, FL 33805 Phone: 863-519-0575 Fax: 863-582-9251 | |
Amanda Gillespie, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3020 S Florida Ave, Lakeland, FL 33803 Phone: 813-290-8560 | |
Ruth Kimmons, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6736 Lunn Rd, Lakeland, FL 33811 Phone: 863-397-4122 |